SEC Contract Filing

Filing Date: 2019-03-07

Document Content:
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>agle-ex104_836.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
agle-ex104_836.htm
</title>
</head>
<!-- NG Converter v5.0.18157.137 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.4</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-variant: small-caps;font-style:normal;text-transform:none;">AEGLEA BIOTHERAPEUTICS, INC.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2016 EMPLOYEE STOCK PURCHASE PLAN</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:8.72%;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">1. PURPOSE.&#160;<font style="font-weight:normal;">Aeglea BioTherapeutics, Inc. has adopted this Plan effective as of the date of the IPO. The purpose of this Plan is to provide eligible employees of the Company and the Participating Corporations with a means of acquiring an equity interest in the Company and to enhance such employees' sense of participation in the Company's affairs. Capitalized terms not defined elsewhere in the text are defined in Section</font><font style="letter-spacing:-0.55pt;font-weight:normal;">&#160;</font><font style="font-weight:normal;">28.</font></p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:8.72%;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2. ESTABLISHMENT OF PLAN.&#160;<font style="font-weight:normal;">The Company proposes to grant rights to purchase shares of Common Stock to eligible employees of the Company and its Participating Corporations pursuant to this Plan. The Company intends this Plan to qualify as an "employee stock purchase plan" under Section 423 of the Code (including any amendments to or replacements of such Sect</font><font style="letter-spacing:-0.15pt;font-weight:normal;">ion),&#160;</font><font style="font-weight:normal;">and this Plan shall be so&#160;</font><font style="letter-spacing:0.05pt;font-weight:normal;">construed</font><font style="font-weight:normal;">, although the Company makes no undertaking or representation to maintain such qualification. Any term not expressly defined in this Plan but defined in Section 423 of the Code shall have the definition provided by Section 423 of the Code. In additi</font><font style="letter-spacing:-0.25pt;font-weight:normal;">on,&#160;</font><font style="font-weight:normal;">with regard to offers of options to purchase shares of Common Stock under the Plan to employees working for a Subsidiary or an Affiliate outside the United&#160;</font><font style="letter-spacing:-0.15pt;font-weight:normal;">States,&#160;</font><font style="font-weight:normal;">this Plan authorizes the grant of options under a Non-Section 423 Component that is not intended to meet the requirements of Section 423 of the Code provided&#160;</font><font style="letter-spacing:-0.2pt;font-weight:normal;">that,&#160;</font><font style="font-weight:normal;">to the extent necessary under Section 423 of the&#160;</font><font style="letter-spacing:-0.15pt;font-weight:normal;">Code,&#160;</font><font style="font-weight:normal;">the other terms and conditions of this Plan are</font><font style="letter-spacing:0.5pt;font-weight:normal;">&#160;</font><font style="font-weight:normal;">met.</font></p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:8.72%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to Section 14, a total of 165,000 shares of Common Stock is reserved for issuance under this Plan. In addition, on each January 1 for each of the calendar years beginning 2019 and ending 2026, the aggregate number of shares of Common Stock reserved for issuance under the Plan shall be increased automatically by the number of shares equal to one percent (1%) of the total number of outstanding shares of Common Stock and Common Stock equivalents outstanding on the immediately preceding December 31 (<font style="text-decoration:underline;">rounded down to the nearest whole share</font>);&#160;<font style="text-decoration:underline;">provided</font>, that the Board may in its sole discretion reduce the amount of the increase in any particular year. Subject to Section 14, no more than 2,900,000 shares of Common Stock may be issued over the term of this Plan. The number of shares initially reserved for issuance under this Plan and the maximum number of shares that may be issued under this Plan shall be subject to adjustments effected in accordance with Section 14. Any or all such shares may be granted under the Section 423 Component.</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:8.72%;font-weight:bold;color:#0F0F0F;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a>3. <font style="color